Vastus Intermedius Dry Needling for Knee Stiffness Resulted From Surgically Managed Femoral Fractures With Open Reduction & Internal Fixation.
Launched by AL-RAZI HOSPITAL · Mar 12, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called dry needling (DN) to help improve knee stiffness that can occur after surgery for a femur fracture. The surgery, known as open reduction and internal fixation (ORIF), is often successful but can lead to complications like difficulty bending the knee. The trial aims to see if DN, which is a minimally invasive technique that helps reduce scar tissue and improve muscle function, can enhance knee movement and overall function for patients who have had this surgery.
To participate in this trial, individuals must be between 18 and 55 years old, have had a specific type of femur fracture treated with ORIF, and be experiencing limited knee movement (less than 90 degrees of bending) three months after their surgery. Participants can expect to receive DN treatment and be monitored for improvements in their knee movement and function. This trial is important because it seeks to provide a potentially effective solution for a common problem faced by many patients recovering from femur fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 to 55-year-old participants.
- • Distal one third femur fractures classified as type 33 with AO/OTA classification.
- • Three months post ORIF surgery to the distal femoral fracture,
- • Experience postoperative limitation in knee flexion range of motion of less than 90 degrees.
- Exclusion Criteria:
- • Neuropathic pain in the lower limb.
- • Lumbosacral radiculopathy,
- • Saphenous nerve entrapment,
- • Meralgia paresthetica,
- • Rheumatoid or systemic conditions,
- • Other surgeries,
- • Post-surgery complications (i.e., thrombosis or osteomyelitis) or use of heparin during DN.
- • Knee surgery,
- • Periprosthetic fractures,
- • Scraw fixation only,
- • Intermedullary nail fixation,
- • non-union,
- • Isolated medial or lateral condyle femoral fractures,
- • Underwent manipulation under anesthesia.
About Al Razi Hospital
Al-Razi Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on evidence-based practices, the hospital serves as a critical hub for clinical studies across various therapeutic areas. Al-Razi Hospital employs a multidisciplinary team of experienced healthcare professionals who collaborate to ensure rigorous adherence to protocols and regulatory standards. By fostering a collaborative environment, the hospital not only enhances the quality of its clinical trials but also contributes to the broader medical community's understanding of disease management and treatment efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported